@article{CJCR1526,
author = {Shun Lu and Mei-lin Liao and Zhen-qiong Lin and Da-wei Zhu},
title = {THE RELATIONSHIP BETWEEN THE PATHOLOGICAL CHANGES AND RESPONSE RATE (RR) IN NON-SMALL CELL LUNG CANCER TREATED BY NEOADJUVANT CHEMOTHERAPY WITH MITOMYCIN (MMC), VINDESINE (VDS) AND CISPLATIN (DDP) COMBINATION},
journal = {Chinese Journal of Cancer Research},
volume = {12},
number = {3},
year = {2013},
keywords = {},
abstract = {Objective: To explore the change of pathology and the clinical response rate treated by neoadjuvant chemotherapy with MVP regimen for non-small cell lung cancer.
Methods: This is a randomized study in patients with stage I-Ilia. Among them, 46 patients enrolled in neoadjuvant chemotherapy treated by 1-2 course MVP regimen. MMC was given 6 mg/M2 by intravenous (I.V.) infusion on dayl, VDS 2.5-3 mg/2 I.V. on day1,8 and/or day15 , DDP 90 mg/2 I.V. on day1. The treatment was recycled every 28 days. The clinical RR evaluated with WHO criteria. All surgical samples were dassified with pathology.
Results: The overall response rate in 2 courses chemotherapy is better than that in 1 course (P},
issn = {1993-0631}, url = {https://cjcr.amegroups.org/article/view/1526}
}